Print

Hi-Tech Pharmacal (HITK) Reports Sales of $50.5 Million for the First Quarter Ended July 31, 2013  
9/9/2013 6:23:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the Company’s fiscal first quarter ended July 31, 2013.

•Net sales of $50.5 million for the first quarter compared to $52.0 million for the same prior year period

•GAAP income of $4.6 million or $0.33 per diluted share for the first quarter

Help employers find you! Check out all the jobs and post your resume.

//-->